|
Volumn 7, Issue 2, 2003, Pages 299-303
|
Emerging developments in RNA therapeutics
|
Author keywords
Aptamers; Cancer; Delivery; eliRNA; mRNA; Ribozymes; RNAi; Silencing; siRNA
|
Indexed keywords
ANGIOZYME;
APTAMER;
CALCITONIN GENE RELATED PEPTIDE;
COMPLEMENTARY RNA;
DACARBAZINE;
DOUBLE STRANDED RNA;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
GENTAMICIN;
HEPTAZYME;
HERZYME;
IRINOTECAN;
KANAMYCIN;
MELITTIN;
NEOMYCIN;
NUCLEIC ACID BIOTOOL;
PACLITAXEL;
POLYETHYLENEIMINE;
RIBOREPORTER;
RIBOREPORTERS;
RIBOSOME RNA;
RIBOZYME;
RNA;
RNA 50S;
RNA BINDING PROTEIN;
RNA DERIVATIVE;
RNA LASSOS;
SMALL INTERFERING RNA DUPLEX;
SPIEGELMER;
SPIEGELMERS;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CANCER;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONFERENCE PAPER;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG HALF LIFE;
GENE EXPRESSION;
GENE SILENCING;
HEPATITIS C;
HUMAN;
METASTASIS;
NONHUMAN;
VIRUS INFECTION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTIVIRAL AGENTS;
APTAMERS, NUCLEOTIDE;
BIOSENSING TECHNIQUES;
CLINICAL TRIALS, PHASE II;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
GENETIC VECTORS;
HEPATITIS C, CHRONIC;
HIV INFECTIONS;
HUMANS;
MICE;
NEOPLASMS;
RNA;
RNA INTERFERENCE;
RNA, SMALL INTERFERING;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0037398147
PISSN: 14728222
EISSN: None
Source Type: Journal
DOI: 10.1517/14728222.7.2.299 Document Type: Conference Paper |
Times cited : (12)
|
References (9)
|